Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shameek Gayen

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
The American Journal of Medicine|May 16, 2022
Malignant Pleural Effusion: Presentation, Diagnosis, and ManagementShameek Gayen
Pulmonary Circulation|April 3, 2023
Predictors of hospitalization for respiratory failure among patients with sarcoidosis-associated pulmonary hypertensionShameek Gayen, Albert J Mamary
Journal of Clinical Medicine|March 17, 2025
The FEV1/DLCO Ratio as an Effective Predictor of Severity and Survival in COPD-Associated Pulmonary Hypertension: A Retrospective AnalysisRia Patel, Jay Pescatore, Shameek Gayen
AACN Advanced Critical Care|June 8, 2023
Pulmonary Point-of-Care Ultrasonography in the Intensive Care UnitShameek Gayen, Jin Sun Kim, Parag Desai
Pulmonary Circulation|February 4, 2025
Revised Precapillary Pulmonary Hypertension Criteria and Their Prognostic Value in IPF Transplant Waitlist SurvivalZehra Dhanani, Michael J Nicholson, Shameek Gayen
Therapeutic Advances in Respiratory Disease|March 14, 2025
Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort studyChristian Cardillo, Gerard J Criner, Shameek Gayen
JHLT Open|March 27, 2025
Pulmonary hypertension and lung transplantation waitlist outcomes for hypersensitivity pneumonitisMichael J Nicholson, Zehra Dhanani, Shameek Gayen
BMC Pulmonary Medicine|February 25, 2026
Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominanceTaylor Caton, Jay Pescatore, Mario Naranjo, et al.
Journal of Cardiovascular Development and Disease|March 27, 2024
Pulmonary Vasodilator Therapy Is Associated with Decreased Mortality in Patients with Chronic Lung Disease and Severe Pulmonary HypertensionOlivia Schanz, Gerard J Criner, Parth Rali, et al.
European Journal of Rheumatology|February 3, 2022
Granulomatosis with polyangiitis: The trigger cannot be long hiddenShameek Gayen, Diana Zhang, Eliza Sternlicht, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The American Journal of Medicine|May 16, 2022
Malignant Pleural Effusion: Presentation, Diagnosis, and ManagementShameek Gayen
Pulmonary Circulation|April 3, 2023
Predictors of hospitalization for respiratory failure among patients with sarcoidosis-associated pulmonary hypertensionShameek Gayen, Albert J Mamary
Journal of Clinical Medicine|March 17, 2025
The FEV1/DLCO Ratio as an Effective Predictor of Severity and Survival in COPD-Associated Pulmonary Hypertension: A Retrospective AnalysisRia Patel, Jay Pescatore, Shameek Gayen
AACN Advanced Critical Care|June 8, 2023
Pulmonary Point-of-Care Ultrasonography in the Intensive Care UnitShameek Gayen, Jin Sun Kim, Parag Desai
Pulmonary Circulation|February 4, 2025
Revised Precapillary Pulmonary Hypertension Criteria and Their Prognostic Value in IPF Transplant Waitlist SurvivalZehra Dhanani, Michael J Nicholson, Shameek Gayen
Therapeutic Advances in Respiratory Disease|March 14, 2025
Antifibrotic therapy combined with pulmonary vasodilator therapy may improve survival in patients with pulmonary fibrosis and pulmonary hypertension: a retrospective cohort studyChristian Cardillo, Gerard J Criner, Shameek Gayen
JHLT Open|March 27, 2025
Pulmonary hypertension and lung transplantation waitlist outcomes for hypersensitivity pneumonitisMichael J Nicholson, Zehra Dhanani, Shameek Gayen
BMC Pulmonary Medicine|February 25, 2026
Pulmonary vasodilator therapy is associated with improved survival in COPD-PH with pulmonary vascular predominanceTaylor Caton, Jay Pescatore, Mario Naranjo, et al.
Journal of Cardiovascular Development and Disease|March 27, 2024
Pulmonary Vasodilator Therapy Is Associated with Decreased Mortality in Patients with Chronic Lung Disease and Severe Pulmonary HypertensionOlivia Schanz, Gerard J Criner, Parth Rali, et al.
European Journal of Rheumatology|February 3, 2022
Granulomatosis with polyangiitis: The trigger cannot be long hiddenShameek Gayen, Diana Zhang, Eliza Sternlicht, et al.
Pageof 3